Erratum: Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: The CRISTAL randomized trial (JAMA - Journal of the American Medical Association (2013) 310, 17 (1809-1817) DOI: 10.1001/jama.2013.280502);Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock - The CRISTAL randomized trial

JAMA

Volumn 310, Issue 17, 2013, Pages 1809-1817

  Annane, Djillali ^a   Siami, Shidasp ^b   Jaber, Samir ^c   Martin, Claude ^d   Elatrous, Souheil ^e   Declère, Adrien Descorps ^f   Preiser, Jean Charles ^g   Outin, Hervé ^h   Troché, Gilles ⁱ   Charpentier, Claire ^j   Trouillet, Jean Louis ^k   Kimmoun, Antoine ^l   Forceville, Xavier ^m   Darmon, Michael ⁿ   Lesur, Olivier ^o   Régnier, Jean ^p   Abroug, Fékri ^q   Berger, Philippe ^r   Clec'H, Christophe ^s   Cousson, Joël ^t   Thibault, Laure ^u   Chevret, Sylvie ⁿ   more..

^a RAYMOND POINCARÉ HOSPITAL   (France)

^b CH d'Etampes   (France)

^c MONTPELLIER UNIVERSITY HOSPITAL   (France)

^d HÔPITAL NORD   (France)

^e Tahar Sfar University Hospital   (Tunisia)

^f HôpitalAntoineBéclère   (France)

^g UNIVERSITY OF LIÈGE   (Belgium)

^h CENTRE HOSPITALIER INTERCOMMUNAL   (France)

ⁱ Département d'Hématologie   (France)

^j UNIVERSITY HOSPITAL OF NANCY   (France)

^k PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^l CHU NANCY BRABOIS   (France)

^m CENTRE HOSPITALIER DE MEAUX   (France)

ⁿ SAINT LOUIS HOSPITAL   (France)

^o CH de Sherbrooke   (Canada)

^p Centre Hospitalier de la Roche sur Yon   (France)

^q FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^r CH de Chalons en Champagne   (France)

^s AVICENNE HOSPITAL   (France)

^t REIMS UNIVERSITY HOSPITAL   (France)

^u CH de la Réunion   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH; HYPERTENSIVE FACTOR; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BELGIUM; CANADA; COLLOID; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CRYSTALLOID; FEMALE; FLUID RESUSCITATION; FLUID THERAPY; FOLLOW UP; FRANCE; HUMAN; HYPOVOLEMIC SHOCK; INJURY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NORTH AFRICA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 84887071739     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.17     Document Type: Erratum

References (22)

1. Oliveira RP, Velasco I, Soriano FG, Friedman G. Clinical review: hypertonic saline resuscitation in sepsis. Crit Care. 2002;6(5):418-423.
2. American Thoracic Society. Evidence-based colloid use in the critically ill: American Thoracic Society Consensus Statement. Am J Respir Crit Care Med. 2004;170(11):1247-1259.
3. Brunkhorst FM, Engel C, Bloos F, et al German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-139.
4. Myburgh JA, Finfer S, Bellomo R, et al CHEST Investigators; Australian and New Zealand Intensive Care Society Clinical Trials Group. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med. 2012;367(20):1901-1911.
5. Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2013;2(2):CD000567.
6. Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA. 2013;309(7):678-688.
7. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350(22):2247-2256.
8. Delaney AP, Dan A, McCaffrey J, Finfer S. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis. Crit Care Med. 2011;39(2):386-391.
9. Dellinger RP, Levy MM, Rhodes A, et al Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580-637.
10. American College of Chest Physicians; Society of Critical Care Medicine Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20(6):864-874.
11. Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE. APACHE-Acute Physiology And Chronic Health Evaluation: a physiologically based classification system. Crit Care Med. 1981;9(8):591-597.
12. McCabe WA, Jackson GG. Gram negative bacteremia, I: etiology and ecology. Arch Intern Med. 1962;110:847-855.
13. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957-2963.
14. Vincent JL, Moreno R, Takala J, et al Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707-710.
15. Kim Y, Jung KY, Kim CY, Kim YI, Shin Y. Validation of the International Classification of Diseases 10th edition-based Injury Severity Score (ICISS). J Trauma. 2000;48(2):280-285.
16. Weinberg PF, Matthay MA, Webster RO, Roskos KV, Goldstein IM, Murray JF. Biologically active products of complement and acute lung injury in patients with the sepsis syndrome. Am Rev Respir Dis. 1984;130(5):791-796.
17. Alderson P, Schierhout G, Roberts I, Bunn F. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2000;(2):CD000567.
18. Whitehead J. The Design and Analysis of Sequential Clinical Trials. 2nd ed. New York, NY: Ellis Horwood; 1992.
19. Weil MH, Shubin H. Proposed reclassification of shock states with special reference to distribution defects. In: Hinshaw LN, Cox BG, eds. The Fundamental Mechanisms of Shock. New York, NY: Plenum Press; 1972:13-23.
20. Perner A, Haase N, Guttormsen AB, et al; 6S Trial Group; Scandinavian Critical Care Trials Group. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis [published correction appears in N Engl J Med. 2012;367:481]. N Engl J Med. 2012;367(2):124-134.
21. Finfer S, Liu B, Taylor C, et al SAFE TRIPS Investigators. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14(5):R185.
22. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA. 2012;308(15):1566-1572.